I'm LongbridgeAI, I can summarize articles.According to the announcement from Ruikang Pharmaceutical (002589.SZ), on July 1, 2025, the company received a notice from the Jiyang District Supervisory Committee of Jinan City, stating that Mr. Li Zhe, the company's director, board secretary, and vice president, has been subjected to detention measures by the Jiyang District Supervisory Committee of Jinan City. Due to Mr. Li Zhe's inability to perform his duties as board secretary during the detention period, in order to ensure the normal operation of the company, according to Article 4.4.7 of the "Shenzhen Stock Exchange Stock Listing Rules (2025 Revision)" and other relevant laws and regulations, Ms. Wang Xiuting, the company's securities affairs representative, will act as the board secretary during Mr. Li Zhe's detention. Currently, the company has made proper arrangements for related work.
The company has a sound governance structure and internal control mechanism. Except for Mr. Li Zhe, the directors, supervisors, and other senior management personnel are performing their duties normally. As of the announcement date, the board of directors and the board of supervisors are operating normally, and the production and operation order of the company and its subsidiaries is normal. This matter will not have a significant impact on the company's normal production and operation
